These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 1324683

  • 1. Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro.
    Colston KW, Chander SK, Mackay AG, Coombes RC.
    Biochem Pharmacol; 1992 Aug 18; 44(4):693-702. PubMed ID: 1324683
    [Abstract] [Full Text] [Related]

  • 2. Comparison of calcipotriol with selected metabolites and analogues of vitamin D3: effects on cell growth regulation in vitro and calcium metabolism in vivo.
    Binderup L.
    Pharmacol Toxicol; 1993 Aug 18; 72(4-5):240-4. PubMed ID: 8396769
    [Abstract] [Full Text] [Related]

  • 3. Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo.
    Binderup L, Bramm E.
    Biochem Pharmacol; 1988 Mar 01; 37(5):889-95. PubMed ID: 2830885
    [Abstract] [Full Text] [Related]

  • 4. EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro.
    Colston KW, Mackay AG, James SY, Binderup L, Chander S, Coombes RC.
    Biochem Pharmacol; 1992 Dec 15; 44(12):2273-80. PubMed ID: 1472092
    [Abstract] [Full Text] [Related]

  • 5. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5.
    Mehta RG, Moriarty RM, Mehta RR, Penmasta R, Lazzaro G, Constantinou A, Guo L.
    J Natl Cancer Inst; 1997 Feb 05; 89(3):212-8. PubMed ID: 9017001
    [Abstract] [Full Text] [Related]

  • 6. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW, Sergeev IN, Bishop JE, Okamura WH.
    Cancer Res; 1993 Sep 01; 53(17):3935-42. PubMed ID: 8395333
    [Abstract] [Full Text] [Related]

  • 7. Calcipotriol (MC 903): pharmacokinetics in rats and biological activities of metabolites. A comparative study with 1,25(OH)2D3.
    Kissmeyer AM, Binderup L.
    Biochem Pharmacol; 1991 Jun 01; 41(11):1601-6. PubMed ID: 2043150
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of insulin- and insulin-like growth factor-I-stimulated growth of human breast cancer cells by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogue EB1089.
    Vink-van Wijngaarden T, Pols HA, Buurman CJ, Birkenhäger JC, van Leeuwen JP.
    Eur J Cancer; 1996 May 01; 32A(5):842-8. PubMed ID: 9081364
    [Abstract] [Full Text] [Related]

  • 9. Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells.
    James SY, Mackay AG, Colston KW.
    J Steroid Biochem Mol Biol; 1996 Jul 01; 58(4):395-401. PubMed ID: 8903423
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antiestrogen potentiation of antiproliferative effects of vitamin D3 analogues in breast cancer cells.
    Love-Schimenti CD, Gibson DF, Ratnam AV, Bikle DD.
    Cancer Res; 1996 Jun 15; 56(12):2789-94. PubMed ID: 8665515
    [Abstract] [Full Text] [Related]

  • 12. Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089.
    VanWeelden K, Flanagan L, Binderup L, Tenniswood M, Welsh J.
    Endocrinology; 1998 Apr 15; 139(4):2102-10. PubMed ID: 9528999
    [Abstract] [Full Text] [Related]

  • 13. EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro.
    James SY, Mercer E, Brady M, Binderup L, Colston KW.
    Br J Pharmacol; 1998 Nov 15; 125(5):953-62. PubMed ID: 9846632
    [Abstract] [Full Text] [Related]

  • 14. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S, Krishnan AV, Feldman D.
    Clin Cancer Res; 2000 Aug 15; 6(8):3371-9. PubMed ID: 10955825
    [Abstract] [Full Text] [Related]

  • 15. Effects of a new synthetic vitamin D analogue, EB1089, on the oestrogen-responsive growth of human breast cancer cells.
    James SY, Mackay AG, Binderup L, Colston KW.
    J Endocrinol; 1994 Jun 15; 141(3):555-63. PubMed ID: 8071654
    [Abstract] [Full Text] [Related]

  • 16. Regulation of cell growth, c-myc mRNA, and 1,25-(OH)2 vitamin D3 receptor in C3H/10T1/2 mouse embryo fibroblasts by calcipotriol and 1,25-(OH)2 vitamin D3.
    Trydal T, Lillehaug JR, Aksnes L, Aarskog D.
    Acta Endocrinol (Copenh); 1992 Jan 15; 126(1):75-9. PubMed ID: 1310564
    [Abstract] [Full Text] [Related]

  • 17. Proliferation and differentiation of cultured human keratinocytes is modulated by 1,25(OH)2D3 and synthetic vitamin D3 analogues in a cell density-, calcium- and serum-dependent manner.
    Svendsen ML, Daneels G, Geysen J, Binderup L, Kragballe K.
    Pharmacol Toxicol; 1997 Jan 15; 80(1):49-56. PubMed ID: 9148283
    [Abstract] [Full Text] [Related]

  • 18. Possible role for vitamin D in controlling breast cancer cell proliferation.
    Colston KW, Berger U, Coombes RC.
    Lancet; 1989 Jan 28; 1(8631):188-91. PubMed ID: 2563099
    [Abstract] [Full Text] [Related]

  • 19. William L. McGuire Memorial Symposium. 1,25(OH)2D3 modulation of mammary tumor cell growth in vitro and in vivo.
    Saez S, Falette N, Guillot C, Meggouh F, Lefebvre MF, Crepin M.
    Breast Cancer Res Treat; 1993 Jan 28; 27(1-2):69-81. PubMed ID: 8260731
    [Abstract] [Full Text] [Related]

  • 20. Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells.
    Simboli-Campbell M, Narvaez CJ, van Weelden K, Tenniswood M, Welsh J.
    Breast Cancer Res Treat; 1997 Jan 28; 42(1):31-41. PubMed ID: 9116316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.